Royal Bank of Canada’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Buy |
247
+215
| +672% | +$870 | ﹤0.01% | 6577 |
|
|
2025
Q1 | $0 | Sell |
32
-11
| -26% | – | ﹤0.01% | 6754 |
|
|
2024
Q4 | $0 | Buy |
+43
| New | – | ﹤0.01% | 6728 |
|
|
2024
Q3 | – | Sell |
-1
| Closed | – | – | 7043 |
|
|
2024
Q2 | $0 | Sell |
1
-73
| -99% | – | ﹤0.01% | 7102 |
|
|
2024
Q1 | $1K | Sell |
74
-203
| -73% | -$2.74K | ﹤0.01% | 6440 |
|
|
2023
Q4 | $4K | Buy |
277
+79
| +40% | +$1.14K | ﹤0.01% | 6159 |
|
|
2023
Q3 | $15K | Buy |
198
+103
| +108% | +$7.8K | ﹤0.01% | 5796 |
|
|
2023
Q2 | $6K | Buy |
+95
| New | +$6K | ﹤0.01% | 6181 |
|
|
2022
Q4 | – | Sell |
-8
| Closed | – | – | 7234 |
|
|
2022
Q3 | $0 | Buy |
8
+6
| +300% | – | ﹤0.01% | 7366 |
|
|
2022
Q2 | $0 | Sell |
2
-51
| -96% | – | ﹤0.01% | 7200 |
|
|
2022
Q1 | $2K | Sell |
53
-159
| -75% | -$6K | ﹤0.01% | 7024 |
|
|
2021
Q4 | $18K | Buy |
212
+135
| +175% | +$11.5K | ﹤0.01% | 6316 |
|
|
2021
Q3 | $6K | Buy |
77
+34
| +79% | +$2.65K | ﹤0.01% | 6576 |
|
|
2021
Q2 | $4K | Buy |
+43
| New | +$4K | ﹤0.01% | 6635 |
|